C. Giles

发表

Interaction between KIR3DS1 and HLA-Bw4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myeloma.

K. Rezvani, D. Marin, L. Foroni, 2010, Blood.

Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients

C. Crawley, J. Goldman, E. Terpos, 2003, Bone Marrow Transplantation.

LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre

I. Lampert, D. Marin, J. Sanz, 2007, Bone Marrow Transplantation.

The significance of tumour cell immunophenotype in myeloma and its impact on clinical outcome

N. Ngo, I. Lampert, K. Naresh, 2009, Journal of Clinical Pathology.

High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma

M. Bua, H. Auner, A. Rahemtulla, 2011, Bone Marrow Transplantation.

Immune neutropenia associated with anti‐human neutrophil antigen‐2a (NB1) antibodies following unrelated donor stem cell transplantation for chronic myeloid leukaemia: perpetuation by granulocyte colony‐stimulating factor

J. Goldman, K. Rezvani, J. Apperley, 2001, British Journal of Haematology.

CD34+‐selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome

A. Bybee, J. Apperley, E. Kanfer, 1999, British journal of haematology.

When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood.

R. Hargreaves, M. Brennan, E. Kanfer, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

LACE‐conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B‐cell lymphoma: treatment outcome and risk factor analysis from a single centre

K. Naresh, H. Auner, A. Rahemtulla, 2011, Hematological oncology.

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours

I. McNeish, M. Seckl, G. Rustin, 2004, British Journal of Cancer.

Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis

C. Mathias, A. Rahemtulla, J. Apperley, 2006, Bone Marrow Transplantation.

Salvage autologous stem cell transplantation for multiple myeloma relapsing or progressing after up-front autologous transplantation

D. Marin, A. Chaidos, H. Auner, 2013, Leukemia & lymphoma.

Autologous haematopoietic stem cell transplantation in multiple myeloma patients from ethnic minority groups in an equal access healthcare system

K. Rezvani, D. Marin, J. Goldman, 2012, British journal of haematology.

Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients

I. Lampert, K. Naresh, E. Terpos, 2006, Bone Marrow Transplantation.

Incidence of hyperthyroidism after unrelated donor allogeneic stem cell transplantation.

D. Marin, G. Williams, J. Apperley, 2007, Leukemia research.

A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins disease

B. Gazzard, A. Chaidos, M. Nelson, 2008, AIDS.

CCNU (lomustine), idarubicin and dexamethasone (CIDEX): an effective oral regimen for the treatment of refractory or relapsed myeloma

D. Samson, C. Giles, S. Kelsey, 2000, British journal of haematology.

High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors.

G. Rustin, M. Bower, E. Kanfer, 1998, British Journal of Cancer.

Lack of correlation between emergence of an abnormal protein band or of oligoclonal bands and survival in patients with multiple myeloma achieving complete remission following autologous stem cell transplantation

K. Naresh, A. Rahemtulla, C. Giles, 2011, Haematologica.

Excess bone marrow B‐cells in patients with multiple myeloma achieving complete remission following autologous stem cell transplantation is a biomarker for improved survival

K. Naresh, A. Rahemtulla, C. Giles, 2011, British journal of haematology.